Serum C‐reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Serum C‐reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma

Published:2012-12 Issue:12 Volume:18 Page:1406-1414
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

An Ho Jung¹,Jang Jeong Won²,Bae Si Hyun²,Choi Jong Young²,Yoon Seung Kew²,Lee Myung Ah¹,You Young Kyoung³,Kim Dong Goo³,Jung Eun Sun⁴

Affiliation:

1. Departments of Medical Oncology, Catholic Medical Center, Catholic University of Korea, Seoul, Korea

2. Departments of Hepatology, Catholic Medical Center, Catholic University of Korea, Seoul, Korea

3. Departments of Surgery, Catholic Medical Center, Catholic University of Korea, Seoul, Korea

4. Departments of Pathology, Catholic Medical Center, Catholic University of Korea, Seoul, Korea

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lt.23512

Reference30 articles.

1. HowladerN NooneAM KrapchoM NeymanN AminouR WaldronW et al. SEER cancer statistics review 1975‐2008.http://seer.cancer.gov/csr/1975_2008. Accessed July2012.

2. Statistics Korea. Cancer statistics.http://kosis.kr/abroad/abroad_03List.jsp?parentId=117_11744 H000. Accessed July2012.

3. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆

4. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis

5. Recurrence of Hepatocellular Carcinoma Following Liver Transplantation

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HBV viral load and tumor and non-tumor factors in patients with HBV-associated HCC;Hepatology Forum;2024

2. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients;BMC Cancer;2023-12-05

3. Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes;Journal of Liver Cancer;2023-09-30

4. Current status and prospect of treatments for recurrent hepatocellular carcinoma;World Journal of Hepatology;2023-02-27

5. Role of Intrahepatic Regional Immunity in Post-Transplant Cancer Recurrence;Engineering;2021-12